Enovis reported a 23% increase in fourth-quarter net sales to $561 million, driven by strong growth in Global Reconstructive. However, the company reported a net loss of $704 million due to a $645 million non-cash goodwill impairment charge. Adjusted EBITDA increased to $113 million, representing 20% of sales.
Fourth-quarter sales grew 23% on a reported basis.
Reconstructive sales increased by 59% year-over-year.
Adjusted EBITDA margin expanded by 210 basis points.
Exceeded year one commercial and integration plans for Lima.
Enovis expects revenue to approximate $2.19-2.22 billion, incorporating 6-6.5% organic revenue growth. Adjusted EBITDA is forecasted to be $405-415 million, representing 60-70 bps expansion Y/Y. Full-year adjusted earnings per share are expected to be in the range of $3.10-$3.25.